ERDERA CLINICAL TRIAL - CALL FOR INFORMATION
A short survey to support ADNP EUROPE participation in a research trial call
10/8/20261 min read
Dear members of ADNP Europe,
As announced during the conference in Antwerp on 11 September 2026, ADNP Europe is currently participating in a research consortium to secure funding for a Phase 3 Trial on Davunetide.
As member of the consortium, we need to provide parent’s view on the potential clinical trial as part of the application process.
Accordingly, a short family questionnaire was drafted and validated by the scientific committee leading the application.
It will take you around 10 mins to fill and it is anonymous. The responses will be registered on a secured folder, compiled and part of the application package we need to submit by the end of this month.
FILL IN THE FORM BY CLICKING HERE
DEADLINE TO COMPLETE IS SET TO 18 OCTOBER 2026
Note: We need one form completed by ADNP Patient. So if you got this questionnaire already filled in through National associations part of the consortium (e.g. ADNP IT) please complete only once and disregard this email.